2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 14, 2025 -- From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D), according to a study published online Aug. 11 in JAMA Network Open.
Michael Fang, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues characterized trends and disparities in glycemic control and use of diabetes technology among U.S. youths and adults with T1D in a serial, cross-sectional analysis using the Optum Labs Data Warehouse.
A total of 186,590 participants with T1D were identified: 26,853 youths (mean age, 12 years) and 159,737 adults (mean age, 45 years). The researchers found an increase in the prevalence of glycemic control (mean hemoglobin A1c <7 percent) from the 2009-2011 to 2021-2023 study periods from 7 to 19 percent in youths and from 21 to 28 percent in adults. During the same period, for youths and adults, there were substantial increases in the percentage of patients using continuous glucose monitoring (4 to 82 percent for youths and 5 to 57 percent for adults); insulin pumps (16 to 50 percent for youths and 11 to 29 percent for adults); and both devices concurrently (1 to 47 percent for youths and 1 to 22 percent for adults). In Hispanic, non-Hispanic Black, and Medicaid-insured youths and adults, the prevalence of glycemic control and use of diabetes technology were lowest; over time, differences persisted or increased.
“Improving glucose control in patients with type 1 diabetes has been challenging, so these big increases are exciting for the field,” Fang said in a statement. “These improvements have likely been driven by the widespread adoption of new monitoring and delivery technologies.”
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Socioeconomic Deprivation Tied to Neurodegeneration in Combat Athletes
THURSDAY, Aug. 14, 2025 -- Athletes experiencing early-life socioeconomic disadvantage may have an increased risk for neurodegeneration from exposure to repetitive head injury...
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality...
Six in 10 Children With Asthma Meet Guideline Diagnostic Criteria
THURSDAY, Aug. 14, 2025 -- Roughly two-thirds of children with pediatrician-diagnosed asthma have a confirmed diagnosis in accordance with international guideline criteria...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.